GILD Tshuag: Nrog Kev Tshaj Tawm Ntawm Kab, Gilead Tshaj Tawm Txog Kev Muag Tshuaj Cancer Loj

Gilead Sciences (GILD) tsoo cov kev cia siab thib peb rau hnub Thursday raws li kev muag khoom ntawm nws cov tshuaj mob qog noj ntshav ze li ob npaug. Cov txiaj ntsig tau ua rau GILD Tshuag siab dua.




X



Daim ntawv tshaj tawm bullish ua raws li kev pom zoo tsis ntev los no rau tus kheej cov tshuaj mob qog noj ntshav Yescarta thiab Tecartus hauv Tebchaws Europe. Ob leeg koom nrog CAR-T chav kawm ntawm cov tshuaj uas tus neeg mob lub cev tiv thaiv kab mob tau qhia kom pom thiab ua kom mob qog noj ntshav. Nyob rau hauv ib xyoos dhau ib xyoos, kev muag khoom ntawm Gilead cov tshuaj mob qog noj ntshav tau nce 79%.

"Hauv oncology, muaj kev xav tau ntau ntxiv rau kev kho ntawm tes thiab Trodelvy," Tus Thawj Saib Xyuas Haujlwm Daniel O'Day tau hais hauv nqe lus sau. Trodelvy kho mob cancer mis thiab uterine. "Zuag qhia tag nrho, peb tab tom pom kev vam meej zoo los ntawm kev lag luam thiab kev saib xyuas kev pom zoo thiab tos ntsoov yuav tsim lub sijhawm no."

Hauv qab-teev trading ntawm hnub no lub khw lag luam, GILD Tshuag tau dhia 1.7% ze 71.40. Thaum lub sijhawm sib tham tas li, cov khoom lag luam poob 0.9% rau 70.20. Shares yog tam sim no tsim ib qab zib nrog ib tug muas point ntawm 74.22, as MarketSmith.com.

GILD Tshuag: HIV Tshuaj Biktarvy Loj hlob bullishly

Thoob plaws tag nrho cov khoom, Gilead qhov muag tau poob 5% rau $ 7 billion. Tab sis qhov ntawd tau zoo dua li kev kwv yees rau $ 6.13 nphom, raws li GILD cov kws tshuaj ntsuam xyuas los ntawm FactSet.

Kho cov nyiaj tau los skidded 28% rau $ 1.90 ib feem tab sis topped forecasts rau $1.43. Gilead tau sau tseg tias cov nyiaj tau los ua rau muaj kev cuam tshuam tom qab kev nrhiav tau ntawm MiroBio, ib tus kheej tuav, UK-based biotech koom nrog hauv kev sim tshuaj uas xaiv thaiv qee qhov ntawm lub cev tiv thaiv kab mob.

Lub tuam txhab kuj tau sau tseg cov khoom lag luam qis thiab cov nyiaj tau los.

Ntawm kev kho mob qog noj ntshav, kev loj hlob zoo tshaj plaws yog los ntawm Yescarta. Kev muag khoom tau nce 81% rau $ 317 lab. Tab sis kev muag khoom me me Tecartus thiab Trodelvy tseem nce qib 72% thiab 78%.

Ntxiv nrog rau kev muag khoom kho mob qog noj ntshav muaj zog, Gilead tau tshaj tawm 22% kev loj hlob rau nws cov tshuaj HIV, Biktarvy. Biktarvy tau tsim $ 2.77 nphom hauv kev muag khoom thib peb, suav txog yuav luag 62% ntawm tag nrho cov tshuaj HIV muag. Gilead kuj tau sau tseg tias nws yeej pom zoo rau cov tshuaj HIV tshiab, lenacapavir, hauv Tebchaws Europe. Cov tshuaj no yuav tsum tau txhaj tshuaj tsawg dua ntawm ib qho tshuaj txhua rau lub hlis.

Bearishly rau GILD Tshuag, Covid kev kho mob Yescarta tsim tau $ 925 lab. Cov kev muag khoom tau poob qis 52% nyob rau hauv qis dua Covid mus pw hauv tsev kho mob thiab tsis tshua muaj mob hnyav.

Kev taw qhia yooj yim saum cov kev kwv yees

Rau lub xyoo, Gilead coj mus rau $ 25.9 nphom rau $ 26.2 nphom hauv cov khoom muag. Qhov ntawd yog $ 1.3 billion siab dua, ntawm qhov nruab nrab, tshaj li lub tuam txhab biotech cov lus qhia peb lub hlis dhau los.

Tsis suav nrog Veklury, Gilead xav kom $ 22.5 nphom rau $ 22.8 nphom hauv kev muag khoom puv xyoo, nce me ntsis los ntawm nws qhov kev kwv yees ua ntej rau $ 22 nphom rau $ 22.5 billion.

Lub tuam txhab tseem cia siab tias cov nyiaj tau los hloov kho ntawm $ 6.95- $ 7.15 ib feem, nce 50 xees ntawm qhov nruab nrab.

Tag nrho cov kev ntsuas tau nce siab tshaj qhov kwv yees nruab nrab ntawm GILD cov kws tshuaj ntsuam xyuas cov nyiaj tau los hloov kho ntawm $ 6.51 ib feem thiab $ 25.28 nphom hauv kev muag khoom.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Yog vim li cas Pandemic Darlings Teladoc, Align Diverged Ntawm Lawv Cov Lus Qhia Peb Lub Peb Hlis

Merck surges nyob rau hauv yuav Zone raws li ob yam khoom tseem ceeb tsav nws Bullish Report

Pom Qhov Kev Lag Luam Zoo Tshaj Plaws Sij Hawm Zoo Nrog IBD Cov Thawj Coj Ua Haujlwm Ntev

Tau Txais Sijhawm Yuav & Muag Alerts Nrog IBD Thawj Coj

Nrhiav Kom Tom Ntej Kua Los Yog Amazon? Pib Nrog Cov S&P 500-Npav Npe

Tau qhov twg los: https://www.investors.com/news/technology/gild-stock-gilead-earnings-q3-2022/?src=A00220&yptr=yahoo